Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions

作者: A. Brooks , A. Ba-Nguz

DOI: 10.1093/HEAPOL/CZS039

关键词: MedicineDisease burdenMalariaIntervention (law)Economic growthDeveloping countryMalaria vaccineAnticipation (artificial intelligence)Psychological interventionUnderdevelopment

摘要: Traditionally it has taken years or decades for new public health interventions targeting diseases found in developing countries to be accessible those most need. One reason the delay been insufficient anticipation of eventual processes and evidence required decision making by countries. This paper describes research into anticipated data needed inform on malaria vaccines, advanced which is still phase 3 trials. From 2006 2008, a series country consultations Africa led development guide assist preparing their vaccine decision-making frameworks. The builds upon World Health Organization’s Vaccine Introduction Guidelines. It identifies decisions, when they would relative timelines intervention, where will come from. Policy supported (e.g. disease burden; roles other interventions; impact; economic financial issues; efficacy, quality safety) as implementation decisions programmatic issues socio-cultural environment). generic can now applied any future vaccine. discusses opportunities challenges early planning decision-making—from potential timely, evidence-informed risks over-promising around an intervention under development. Careful well-structured important way ensure that do not remain unused after become available.

参考文章(31)
J Jitta, Wani J Arube, L Arinaitwe, R A Katahoire, E Mugisha, G Siu, D Murokora, G Kivumbi, D S LaMontagne, A Bingham, V Tsu, An assessment of the readiness for introduction of the HPV vaccine in Uganda. African Journal of Reproductive Health. ,vol. 12, pp. 159- 172 ,(2008)
J-A. Mulligan, R. Mandike, N. Palmer, H. Williams, S. Abdulla, P. Bloland, A. Mills, The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania Tropical Medicine & International Health. ,vol. 11, pp. 452- 461 ,(2006) , 10.1111/J.1365-3156.2006.01590.X
Violaine Mitchell, Damian Walker, Patrick Zuber, Patrick Lydon, Mercy Ahun, Evidenced-based decision making about Hib vaccination. The Lancet. ,vol. 365, pp. 936- 937 ,(2005) , 10.1016/S0140-6736(05)71076-X
Abdinasir A Amin, Dejan Zurovac, Beth B Kangwana, Joanne Greenfield, Dorothy N Otieno, Willis S Akhwale, Robert W Snow, The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya Malaria Journal. ,vol. 6, pp. 72- 72 ,(2007) , 10.1186/1475-2875-6-72
Denise DeRoeck, John D. Clemens, Andrew Nyamete, Richard T. Mahoney, Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia Vaccine. ,vol. 23, pp. 2762- 2774 ,(2005) , 10.1016/J.VACCINE.2004.11.044
R. Shretta, J. Omumbo, B. Rapuoda, R. W. Snow, Using evidence to change antimalarial drug policy in Kenya. Tropical Medicine & International Health. ,vol. 5, pp. 755- 764 ,(2000) , 10.1046/J.1365-3156.2000.00643.X